Arlo-cel Phase I Data in Refractory Myeloma

Online-First June 2, 2026 · Issue Date September 3, 2026 · Discovery September 4, 2026 · Status Publication catch-up · Importance 5/5 · Direction Positive Summary Peer-reviewed Phase I results for arlocabtagene autoleucel (arlo-cel; BMS-986393; CC-95266), an autologous GPRC5D-directed CAR-T therapy, show clinically meaningful activity…